Timothy P. Spiro

978 total citations
32 papers, 700 citations indexed

About

Timothy P. Spiro is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Timothy P. Spiro has authored 32 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Cancer Research and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Timothy P. Spiro's work include Lymphoma Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (5 papers) and Bone health and treatments (4 papers). Timothy P. Spiro is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (5 papers) and Bone health and treatments (4 papers). Timothy P. Spiro collaborates with scholars based in United States, Mexico and United Kingdom. Timothy P. Spiro's co-authors include Hamed Daw, Stanton L. Gerson, James K. V. Willson, Madappa N. Kundranda, Baidehi Maiti, Susan M. Majka, John R. Haaga, Stephen T. Ingalls, Charles L. Hoppel and Alaa Muslimani and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Timothy P. Spiro

31 papers receiving 675 citations

Peers

Timothy P. Spiro

ONCOL

PRM

PFM

Charlotte Vaysse France

L. Austin Doyle United States

Walid A. Mourad Saudi Arabia

Sally Baron‐Hay Australia

Miaoxia He China

Keisuke Aiba Japan

Lucio Manenti Italy

Antonio De Leo Italy

A. Boots Netherlands

David Topolsky United States

Charlotte Vaysse France

Timothy P. Spiro

293 ×1.0

ONCOL

188 ×0.7

162 ×1.0

75 ×0.6

PRM

56 ×0.5

PFM

Citations per year, relative to Timothy P. Spiro Timothy P. Spiro (= 1×) peers Charlotte Vaysse

Countries citing papers authored by Timothy P. Spiro

Since Specialization

Citations

This map shows the geographic impact of Timothy P. Spiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy P. Spiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy P. Spiro more than expected).

Fields of papers citing papers by Timothy P. Spiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy P. Spiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy P. Spiro. The network helps show where Timothy P. Spiro may publish in the future.

Co-authorship network of co-authors of Timothy P. Spiro

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy P. Spiro. A scholar is included among the top collaborators of Timothy P. Spiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy P. Spiro. Timothy P. Spiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Covut, Fahrettin, Tariq Kewan, Hassan Awada, et al.. (2019). Direct oral anticoagulants (DOAC) versus warfarin and enoxaparin in ovarian vein thrombosis.. Journal of Clinical Oncology. 37(15_suppl). e14698–e14698. 2 indexed citations

Kawsar, Hameem I., et al.. (2012). Hepatitis B reactivation in cancer patients: role of prechemotherapy screening and antiviral prophylaxis.. PubMed. 10(6). 370–8. 18 indexed citations

Kawsar, Hameem I., et al.. (2011). BOOP as a rare complication of gemcitabine therapy. BMJ Case Reports. 2011. bcr0420114055–bcr0420114055. 3 indexed citations

Spiro, Timothy P., et al.. (2011). Pulmonary toxicities of tyrosine kinase inhibitors.. PubMed. 9(11). 824–36. 30 indexed citations

Maiti, Baidehi, Madappa N. Kundranda, Timothy P. Spiro, & Hamed Daw. (2009). The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Research and Treatment. 121(2). 479–483. 118 indexed citations

Spiro, Timothy P., et al.. (2009). 5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenocarcinoma of the small bowel.. Europe PMC (PubMed Central). 6 indexed citations

Muslimani, Alaa, et al.. (2009). Venous Thromboembolism in Lymphoma. American Journal of Clinical Oncology. 32(5). 521–523. 5 indexed citations

Spiro, Timothy P., et al.. (2009). Pulmonary toxicities of biologics: a review. Anti-Cancer Drugs. 21(2). 131–139. 19 indexed citations

Muslimani, Alaa, et al.. (2009). Aromatase Inhibitor–Related Musculoskeletal Symptoms: Is Preventing Osteoporosis the Key to Eliminating These Symptoms?. Clinical Breast Cancer. 9(1). 34–38. 33 indexed citations

10.

Boughan, Kirsten M, et al.. (2009). A Renal Mass in a Patient With Melanoma. Clinical Genitourinary Cancer. 7(3). E98–E100. 2 indexed citations

11.

Muslimani, Alaa, et al.. (2008). The Utility of 18-F-Fluorodeoxyglucose Positron Emission Tomography in Evaluation of Bone Marrow Involvement by Non-Hodgkin Lymphoma. American Journal of Clinical Oncology. 31(5). 409–412. 26 indexed citations

12.

Kundranda, Madappa N., Alaa Muslimani, Hamed Daw, & Timothy P. Spiro. (2007). Complete Remission of Metastatic Carcinoma of the Prostate with Bicalutamide Withdrawal. Clinical Genitourinary Cancer. 5(6). 401–402. 1 indexed citations

13.

Nihal, Minakshi, Debra Mikkola, N. Horvath, et al.. (2003). Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Human Pathology. 34(6). 617–622. 75 indexed citations

14.

Tserng, Kou‐Yi, Stephen T. Ingalls, Erik M. Boczko, et al.. (2003). Pharmacokinetics of O⁶‐Benzylguanine (NSC637037) and Its Metabolite, 8‐Oxo‐O⁶‐Benzylguanine. The Journal of Clinical Pharmacology. 43(8). 881–893. 14 indexed citations

15.

Gilliam, Anita C., et al.. (2001). Primary Cutaneous Large B-Cell Lymphoma of the Leg Relapsing as Cutaneous Intravascular Large B-Cell Lymphoma. Archives of Dermatology. 137(12). 1657–1657. 3 indexed citations

16.

Spiro, Timothy P., Stanton L. Gerson, Lili Liu, et al.. (1999). O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.. PubMed. 59(10). 2402–10. 106 indexed citations

17.

Parry, Eileen, Seth R. Stevens, Anita C. Gilliam, et al.. (1999). Management of Cutaneous Lymphomas Using a Multidisciplinary Approach. Archives of Dermatology. 135(8). 907–11. 8 indexed citations

18.

Stefan, Tammy, Stephen T. Ingalls, Paul E. Minkler, et al.. (1997). Simultaneous determination of O6-benzylguanine and 8-oxo-O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 704(1-2). 289–298. 7 indexed citations

19.

Klioze, Sol S., M. F. Miller, & Timothy P. Spiro. (1988). A Randomized, Comparative Study of Buserelin with DES/Orchiectomy in the Treatment of Stage D2 Prostatic Cancer Patients. American Journal of Clinical Oncology. 11. S176–182. 18 indexed citations

20.

Klioze, Sol S., M. F. Miller, & Timothy P. Spiro. (1987). A randomized, comparative study of buserelin with des/orchiectomy in the treatment stage D2 prostatic cancer patients. European Journal of Cancer and Clinical Oncology. 23(8). 1242–1242. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact